Catalyst Wire Dossier Catalyst Wire Dossier

Idursulfase

idursulfase · Shire
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Idursulfase, covering 2013-11-07 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) [Phase 2, Phase 3]

See pricing